We highly recommend enabling Javascript while using the BlackBoxRX site.


Contraindicated for use in CHF patients

  • Cilostazol and several of its metabolites are inhibitors of phosphodiesterase III. Such activity has been shown to decrease survival compared to placebo in patients with class III-IV CHF.
  • Contraindicated in patients with CHF of any severity.

Patient Counseling Information

Package Inserts


Additional Information

Updated January 2018